KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

COMPEL: osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC and progression on first-line osimertinib.

ESMO Open · 2025-Oct · PMID 41139117

Panel Progression-free_survival_PFS_提取失败待 EXE 对齐验证

Progression-free survival (PFS)

Figure 1 Kaplan–Meier curve of progression-free survival (PFS) (full analysis set). Data cut-off: 28 October 2024. The crosses indicate censored observations. Progression events that did not occur within two missed visits of the last evaluable assessment were censored. The hazard ratio (HR) and confidence interval (CI) were calculated using a log-rank test.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.16
质量通过否
预期曲线2
实际曲线0
X 范围-
Y 范围0 – 1
No curves extracted

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0failed待验证02026-07-23T17:13:59+00:00